Search

everythinglearnresearchcommunity

for

Search:↓

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

Older people often have untreated genital skin diseases due to embarrassment and lack of medical attention, which can lead to discomfort and even cancer risk.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Hair loss in lupus patients indicates higher disease activity.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

High doses of tryptophan may cause eosinophilic fasciitis.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

EMS and EF both show similar skin and fascia changes, but EMS has more severe symptoms and nerve inflammation.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.